A subgroup with high expression of GFPT2 (Fig. 7C) was identified as the CAFs, which promote metabolism reprogramming by activating the hexosamine biosynthesis pathway in NSCLC [68]. This evidence concerns the gene GFPT2 and non-small cell lung carcinoma.